Therefore, in this study, we investigate the frequency of LPL-Hind III and APO CII-Ava II polymorphism in patients with severe hypertriglyceridemia not suffering from any secondary cause, as well as a group of normotriglyceridemia subjects. This evidence concerns the gene AOPEP and hypertriglyceridemia.